New York 2025-2026 Regular Session

New York Assembly Bill A01057

Introduced
1/8/25  
Refer
1/8/25  

Caption

Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations to negate or neutralize, in whole or in part, the pharmacological effects of an opioid in the human body.

Companion Bills

No companion bills found.

Previously Filed As

NY A10060

Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as optional part of required health education courses; authorizes certain students to administer non-intravenous opioid antagonists.

NY HB1285

Health - Opioid Overdose Reversal Drugs - Possession, Storage, and Administration Past Expiration Date

NY A01921

Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain.

NY S03185

Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain.

NY S08569

Requires inpatient facilities to dispense at-risk individuals with opioid reversal drugs upon discharge.

NY S07126

Authorizes the imposition of bail for certain offenses involving the sale or possession with intent to sell of a controlled substance or a synthetic opioid.

NY S04150

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

NY H2217

Relative to opioid reversal drugs

NY S08153

Requires opioid antagonists in student gathering places at colleges and universities; requires college and university emergency medical services to carry and have readily available opioid antagonists.

NY A00265

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Similar Bills

No similar bills found.